JILL ANDERSON: Open Payments
NPI 1538463971 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,819 in 35 payments from 12 companies in 2025. Trend: 2023 $241 · 2024 $1,255 · 2025 $1,819
Food & beverage: $1,819
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $428 |
| AstraZeneca Pharmaceuticals LP | 3 | $270 |
| Medtronic, Inc. | 1 | $162 |
| Novo Nordisk Inc | 7 | $158 |
| Lilly USA, LLC | 2 | $151 |
| ABBVIE INC. | 2 | $150 |
| Phathom Pharmaceuticals, Inc. | 3 | $133 |
| SANOFI-AVENTIS U.S. LLC | 1 | $122 |
| bioMerieux Inc | 1 | $103 |
| Radius Health, Inc. | 1 | $94 |
Products named: CAPLYTA, AIRSUPRA, PERCEPT PC BRAINSENSE, VOQUEZNA, VRAYLAR, ZEPBOUND, TZIELD, FILMARRAY.
Industry payments across FL — which companies pay providers there.
